메뉴 건너뛰기




Volumn 20, Issue 14, 2012, Pages 4390-4396

Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro

Author keywords

Anticancer activity; CK2; Human prostate cancer cell line LCNaP; Kinase inhibitors; Tetrahalogenobenzimidazoles

Indexed keywords

2 BROMO 4,5,6,7 TETRAIODO 1 METHYL 1H BENZIMIDAZOLE; 4,5,6,7 TETRABROMOBENZIMIDAZOLE; 4,5,6,7 TETRAIODOBENZIMIDAZOLE; ANTINEOPLASTIC AGENT; CASEIN KINASE II; N (4,5,6,7 TETRABROMO 1H BENZIMIDAZOL 2 YL) BUTANE 1,2 DIAMINE; N (4,5,6,7 TETRABROMO 1H BENZIMIDAZOL 2 YL) ETHANE 1,2 DIAMINE; N (4,5,6,7 TETRABROMO 1H BENZIMIDAZOL 2 YL) PROPANE 1,2 DIAMINE; N (4,5,6,7 TETRABROMO METHYL 1H BENZIMIDAZOL 2 YL) ETHANE 1,2 DIAMINE; N (4,5,6,7 TETRAIODO 1 METHYL 1H BENZIMIDAZOL 2 YL) ETHANE 1,2 DIAMINE; N (4,5,67 TETRAIODO 1H BENZIMIDAZOLE 2 YL) ETHANE 1,2 DIAMINE; N N DIMETHYL N (4,5,6,7 TETRABROMO 1H BENZIMIDAZOL 2 YL) ETHANE 1,2 DIAMINE; N,N DIMETHYL N (4,5,6,7 TETRAIDO 1H BENZIMIDAZOL 2 YL) ETANE 1,2 DIAMINE; UNCLASSIFIED DRUG;

EID: 84863206953     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2012.05.038     Document Type: Article
Times cited : (18)

References (43)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.